Bromoacetonitrile → HCID 118598704, compound
Reaction equation
Cl.[NH2:2][C:3]1[N:8]=[CH:7][N:6]=[C:5]([NH:9][C:10]2[C:15](=[O:16])[N:14]3[C:17]4([NH:23][C:24](=[O:25])[C:13]3=[C:12]([CH3:26])[CH:11]=2)[CH2:22][CH2:21][NH:20][CH2:19][CH2:18]4)[C:4]=1[Cl:27].[CH:28]([N:31](CC)C(C)C)(C)[CH3:29].BrCC#N>CN(C)C=O.[Cl-].[NH4+]>[NH2:2][C:3]1[N:8]=[CH:7][N:6]=[C:5]([NH:9][C:10]2[C:15](=[O:16])[N:14]3[C:17]4([NH:23][C:24](=[O:25])[C:13]3=[C:12]([CH3:26])[CH:11]=2)[CH2:22][CH2:21][N:20]([CH2:29][C:28]#[N:31])[CH2:19][CH2:18]4)[C:4]=1[Cl:27]Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 2
Procedure
6-((6-Amino-5-chloropyrimidin-4-yl)amino)-8-methyl-2H-spiro[imidazo[1,5-a]pyridine-3,4′-piperidine]-1,5-dione hydrochloride (5, 75 mg, 0.20 mmol) was dissolved in dimethylformamide (5 mL). To this mixture N,N-diisopropylethylamine (77 mg, 0.60 mmol) and bromoacetonitrile (36 mg, 0.30 mmol) were added. The reaction mixture was stirred at room temperature for 2 h. After completion reaction mixture was diluted with saturated ammonium chloride solution (50 mL). The yellow precipitate out was filtered and dried under reduced pressure. The crude was purified by prep purification to afford 2-(6-((6-amino-5-chloropyrimidin-4-yl)amino)-8-methyl-1,5-dioxo-1,5-dihydro-2H-spiro[imidazo[1,5-a]pyridine-3,4′-piperidin]-1′-yl)acetonitrile (Cpd. No. 238) as white solid. Yield: 14 mg, 17%; MS (ESI) m/z 414.85 [M+1]+; 1H NMR (400 MHz, DMSO-d6 with d1-TFA) δ 8.49 (s, 1H), 8.33 (s, 1H), 4.49 (s, 2H), 3.76-3.71 (m, 2H), 3.58-3.41 (m, 4H), 2.42 (s, 3H), 1.90-1.87 (m, 2H).
Workup
- customAfter completion reaction mixture
- filtrationThe yellow precipitate out was filtered
- customdried under reduced pressure
- customThe crude was purified by prep purification
Sources & evidence
- ORD record
- ord-c61e8eb89237491d88602b2c3e33a9e0
- Source dataset
- uspto-grants-2016_07
- Patent number
- US09382248B2
Reaction notes
Loading…